Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page
- CheckyesterdayChange DetectedAdded a new publication citation about BRAF p.V600E mutation monitoring in cerebrospinal fluid during BRAF/MEK inhibitor therapy for papillary craniopharyngioma to the study's publications section.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor update to the page’s backend or content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, reflecting a new revision of the page without changes to study details or core content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor version update. This change does not modify the study details or other essential information displayed to users.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision badge updated from v3.6.0 to v3.6.2, indicating a minor update to the page rendering and metadata.SummaryDifference0.0%

- Check65 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and results have been posted. The page also includes added help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'.SummaryDifference2%

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.